rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
1998-2-6
|
pubmed:abstractText |
Invasive lobular carcinoma (ILC) accounts for 5% to 10% of all invasive breast cancers. Although breast conservation therapy using local excision and postoperative irradiation is a standard therapy for early invasive ductal breast cancer, the result of this strategy in ILC is not well documented. We sought to determine the rate of locoregional recurrence after breast conservation therapy in patients with ILC.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1068-9265
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
650-4
|
pubmed:dateRevised |
2007-7-18
|
pubmed:meshHeading |
pubmed-meshheading:9416413-Adult,
pubmed-meshheading:9416413-Aged,
pubmed-meshheading:9416413-Aged, 80 and over,
pubmed-meshheading:9416413-Breast Neoplasms,
pubmed-meshheading:9416413-Carcinoma, Lobular,
pubmed-meshheading:9416413-Disease-Free Survival,
pubmed-meshheading:9416413-Female,
pubmed-meshheading:9416413-Humans,
pubmed-meshheading:9416413-Logistic Models,
pubmed-meshheading:9416413-Mastectomy, Segmental,
pubmed-meshheading:9416413-Middle Aged,
pubmed-meshheading:9416413-Neoplasm Recurrence, Local,
pubmed-meshheading:9416413-Radiotherapy, Adjuvant,
pubmed-meshheading:9416413-Retrospective Studies
|
pubmed:year |
1997
|
pubmed:articleTitle |
Role of conservation therapy for invasive lobular carcinoma of the breast.
|
pubmed:affiliation |
Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
|
pubmed:publicationType |
Journal Article
|